July 26, 2017
Amgen has entrusted us with the representation of two new licences: Neupogen (filgrastim) and Neulastim (pegfilgrastim). We are proud to continue expanding our portfolio, commiting ourselves to improving the quality of life for patients, with more treatment opportunitiessee more
September 28, 2017
KYPROLIS®: Significantly improves overall survival in patients with relapsed multiple myeloma, demonstrated in two Phase 3 Studies.see more
From its beginnings, VARIFARMA has conceived its international presence as a strategic objective, rooted in its pharmaceutical development and production in Argentina. In strict compliance with GMP and GLP requirements, with certification granted by the regulatory bodies of the countries where our products are sold, it was not until 2004 that the company decided to promote the international development of our products, as a first step toward the laboratory expansion.
At Laboratorio Varifarma’s pharmaceutical manufacturing plant, the company manufactures solid medical specialties in the form of (tablets, coated tablets, hard capsules); at its newly inaugurated facility, pharmaceutical dosage forms for injection (lyophilized vials and pre-filled ampoules) are prepared.
Our facilities meet the good manufacturing practices (GMP) requirements in regard to surfaces, ceilings, lighting and air supplies. Our Standard Operating Procedures (SOPs) guarantee the quality of the various operations, thus ensuring the quality of the products produced by our laboratory.